Emiliem's Seed Round

Emiliem raised a round of funding on , . Investors include Michigan Pre-Seed Capital Fund.

Emiliem, Inc., a biopharmaceutical company, is engaged in early oncology R&D. The Company is developing Molecular Targeted Therapeutics (MTTs) for oncology and other indications. MTTs are therapeutic …

Articles about Emiliem's Seed Round: